These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31729074)
1. Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire. Yotsu RR; Murase C; N'guessan K; Yao A; Kouadio K; N'Golo DC; N'Guetta A; Akiyama M; Constance K; Vagamon B J Dermatol; 2020 Feb; 47(2):e64-e65. PubMed ID: 31729074 [No Abstract] [Full Text] [Related]
2. Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire. Bahadoran P; Hammoudi N; Gaudart A; Saad J; Di Filippo Y; Drancourt M; Ruimy R Am J Trop Med Hyg; 2021 Apr; 104(5):1782-1783. PubMed ID: 33819173 [TBL] [Abstract][Full Text] [Related]
3. Integrated approach in the control and management of skin neglected tropical diseases in three health districts of Côte d'Ivoire. Koffi AP; Yao TAK; Barogui YT; Diez G; Djakeaux S; Zahiri MH; Sopoh GE; Santos S; Asiedu KB; Johnson RC; Assé H BMC Public Health; 2020 Apr; 20(1):517. PubMed ID: 32303204 [TBL] [Abstract][Full Text] [Related]
15. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740 [TBL] [Abstract][Full Text] [Related]
16. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556 [TBL] [Abstract][Full Text] [Related]
17. The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series. Jerjen R; Moodley A; Sinclair R Australas J Dermatol; 2020 Nov; 61(4):376-377. PubMed ID: 32578188 [No Abstract] [Full Text] [Related]
18. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Phillips RO; Sarfo FS; Abass MK; Abotsi J; Wilson T; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M Antimicrob Agents Chemother; 2014; 58(2):1161-6. PubMed ID: 24323473 [TBL] [Abstract][Full Text] [Related]
19. [Micronecta sp (Corixidae) and Diplonychus sp (Belostomatidae), two aquatic Hemiptera hosts and/or potential vectors of Mycobacterium ulcerans (pathogenic agent of Buruli ulcer) in Cote d'Ivoire]. Doannio JM; Konan KL; Dosso FN; Koné AB; Konan YL; Sankaré Y; Ekaza E; Coulibaly ND; Odéhouri KP; Dosso M; Sess ED; Marsollier L; Aubry J Med Trop (Mars); 2011 Feb; 71(1):53-7. PubMed ID: 21585092 [TBL] [Abstract][Full Text] [Related]